Europe Blood Collection Tubes for Liquid Biopsy Market Forecast to 2031 - Regional Analysis - by Product, Material, Application, and End User

Description

List of Tables

The Europe blood collection tubes for liquid biopsy market was valued at US$ 30,949.00 million in 2023 and is expected to reach US$ 1,21,742.27 million by 2031; it is estimated to register a CAGR of 18.7% from 2023 to 2031.

Advantages of Liquid Biopsy Over Other Diagnostic Testing Techniques Drive Europe Blood Collection Tubes for Liquid Biopsy Market

Invasive diagnostic procedures increase the risk of hematoma, hemorrhage, and tissue damage, seeding tumor cells in surrounding tissues. As a result, there is a growing preference for noninvasive or minimally invasive tests among patients for diagnostic purposes. Researchers can trace all genetic and epigenetic changes in solid tumors through the liquid biopsy of blood samples. Patients are at lesser risk with liquid biopsies, since it is a noninvasive technique of diagnosis. Moreover, clinicians can readily conduct these tests multiple times, as the procedures don't subject patients to much discomfort. Patients prefer minimally invasive procedures due to the use of advanced instruments, which allow clinicians or laboratory personnel to perform more delicate and complex work with less pain, scarring, and risk. Liquid biopsy has recently gathered considerable interest as a noninvasive alternative to tissue biopsy in cancer patients, owing to technological advancements contributing to improved feasibility and reduced processing times.

Computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scan, among other imaging techniques, are expensive and time-consuming. Moreover, they expose patients to external radiation, intravenous contrast, and radioactive tracers, among others. Imaging studies also fail to provide any information about the phenotype of the tumor, which can change with the treatment given. Although tissue biopsy techniques can offer information on tumor phenotype information, it is not feasible to perform serial tissue biopsies, considering cost limitations and risks to patients. Liquid biopsy, on the contrary, could provide a virtually continuous assessment of cancer burden and phenotype information at a relatively low cost. Liquid biopsy offers noninvasive or minimally invasive means of assessing various physiological or pathophysiological processes, thereby replacing tissue biopsy or other invasive procedures. Liquid biopsy, in this case, could circumvent the need for endoscopy, needle biopsy, or surgery by analyzing a blood sample for circulating tumor cells or circulating free nucleic acids.

Europe Blood Collection Tubes for Liquid Biopsy Market Overview

According to the "Lung Cancer in Germany" article, published in the Journal of Thoracic Oncology in June 2022, cancer is among the second most frequent cause of death in Germany, accounting for 25% of all deaths. With an age-standardized incidence rate of 52.1% and 32.7% (per 100,000) in men and women, respectively. The average age at which individuals are diagnosed with cancer is 70 years in men and 69 years in women, and 52% of the total patients are at stage IV. The increasing prevalence of cancer thus fuels the growth of the blood collection tubes for liquid biopsy market in Germany. Moreover, BARMER covers the OncoBEAM RAS CRC IVD Test performed in colorectal cancer patients. This innovative liquid biopsy diagnostic method delivers a comprehensive evaluation of RAS mutations using blood volume as low as a single tube. This reimbursement option marks an important milestone in the modernization of oncology care, granting patients access to critical information for the timely selection of the most appropriate therapy.

Europe Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2031 (US$ Million)

Europe Blood Collection Tubes for Liquid Biopsy Market Segmentation

The Europe blood collection tubes for liquid biopsy market is categorized into product, material, application, end user, country.

By product, the Europe blood collection tubes for liquid biopsy market is segmented into ccfDNA/cfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, intracellular RNA Tubes, and others. The ccfDNA/cfDNA Tubes segment held the largest share of the Europe blood collection tubes for liquid biopsy market share in 2023.

In terms of material, the Europe blood collection tubes for liquid biopsy market is segmented into plastic and glass. The plastic segment held a larger share of the Europe blood collection tubes for liquid biopsy market share in 2023.

By application, the Europe blood collection tubes for liquid biopsy market is bifurcated into in-vitro diagnostics (IVD) and research. The in-vitro diagnostics (IVD) segment held a larger share of the Europe blood collection tubes for liquid biopsy market share in 2023.

In terms of end user, the Europe blood collection tubes for liquid biopsy market is segmented into genetic diagnostic labs, research and development centers, conventional diagnostic centers, and others. The genetic diagnostic labs segment held the largest share of the Europe blood collection tubes for liquid biopsy market share in 2023.

Based on country, the Europe blood collection tubes for liquid biopsy market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe blood collection tubes for liquid biopsy market in 2023.

Biocept Inc; Exact Sciences Corp; F. Hoffmann-La Roche Ltd; Greiner Bio-One International GmbH; MagBio Genomics, Inc; Norgen Biotek Corp; QIAGEN NV; Streck Inc; and Zymo Research Corporation are some of the leading companies operating in the Europe blood collection tubes for liquid biopsy market.

Product Code: TIPRE00027974

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics

4.1 Europe Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics
4.2 Market Drivers:
- 4.2.1 Increase in Prevalence of Cancer
- 4.2.2 Advantages of Liquid Biopsy Over Other Diagnostic Testing Techniques
4.3 Market Restraints
- 4.3.1 Lack of Skilled Professionals
4.4 Market Opportunities
- 4.4.1 Use of Liquid Biopsy in Cancer Monitoring
4.5 Future Trends
- 4.5.1 Technological Advancements in Liquid Biopsy
4.6 Impact of Drivers and Restraints:

5. Blood Collection Tubes for Liquid Biopsy Market - Europe Analysis

5.1 Europe Blood Collection Tubes for Liquid Biopsy Market Revenue (US$ Thousand), 2021-2031
5.2 Europe Blood Collection Tubes for Liquid Biopsy Market Forecast Analysis

6. Europe Blood Collection Tubes for Liquid Biopsy Market Analysis - by Product

6.1 ccfDNA/cfDNA Tubes
- 6.1.1 Overview
- 6.1.2 ccfDNA/cfDNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
6.2 cfRNA Tubes
- 6.2.1 Overview
- 6.2.2 cfRNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
6.3 CTC Tubes
- 6.3.1 Overview
- 6.3.2 CTC Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
6.4 gDNA Tubes
- 6.4.1 Overview
- 6.4.2 gDNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
6.5 Intracellular RNA Tubes
- 6.5.1 Overview
- 6.5.2 Intracellular RNA Tubes: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

7. Europe Blood Collection Tubes for Liquid Biopsy Market Analysis - by Material

7.1 Plastic
- 7.1.1 Overview
- 7.1.2 Plastic: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
7.2 Glass
- 7.2.1 Overview
- 7.2.2 Glass: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Europe Blood Collection Tubes for Liquid Biopsy Market Analysis - by Application

8.1 In-vitro Diagnostics (IVD)
- 8.1.1 Overview
- 8.1.2 In-vitro Diagnostics (IVD): Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
8.2 Research
- 8.2.1 Overview
- 8.2.2 Research: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Europe Blood Collection Tubes for Liquid Biopsy Market Analysis - by End User

9.1 Genetic Diagnostic Labs
- 9.1.1 Overview
- 9.1.2 Genetic Diagnostic Labs: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
9.2 Research and Development Centres
- 9.2.1 Overview
- 9.2.2 Research and Development Centres: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
9.3 Conventional Diagnostic Centres
- 9.3.1 Overview
- 9.3.2 Conventional Diagnostic Centres: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

10. Europe Blood Collection Tubes for Liquid Biopsy Market - Country Analysis

10.1 Europe Blood Collection Tubes for Liquid Biopsy Market, by Key Countries - Revenue (2023) US$ Million
- 10.1.1 Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 10.1.1.1.1 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
    - 10.1.1.1.2 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
    - 10.1.1.1.3 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
    - 10.1.1.1.4 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
  - 10.1.1.2 Germany: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 10.1.1.2.1 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
    - 10.1.1.2.2 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
    - 10.1.1.2.3 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
    - 10.1.1.2.4 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
  - 10.1.1.3 France: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 10.1.1.3.1 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
    - 10.1.1.3.2 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
    - 10.1.1.3.3 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
    - 10.1.1.3.4 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
  - 10.1.1.4 Italy: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 10.1.1.4.1 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
    - 10.1.1.4.2 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
    - 10.1.1.4.3 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
    - 10.1.1.4.4 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
  - 10.1.1.5 Spain: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 10.1.1.5.1 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
    - 10.1.1.5.2 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
    - 10.1.1.5.3 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
    - 10.1.1.5.4 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
  - 10.1.1.6 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 10.1.1.6.1 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
    - 10.1.1.6.2 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
    - 10.1.1.6.3 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
    - 10.1.1.6.4 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User

11. Blood Collection Tubes for Liquid Biopsy Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in Blood Collection Tubes for Liquid Biopsy Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Biocept Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Streck Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 MagBio Genomics, Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Zymo Research Corporation
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Norgen Biotek Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Exact Sciences Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 QIAGEN NV
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Greiner Bio-One International GmbH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners